These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 2874213)
21. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
22. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis. Nisoli E; Tonello C; Memo M; Carruba MO J Pharmacol Exp Ther; 1992 Nov; 263(2):823-9. PubMed ID: 1359119 [TBL] [Abstract][Full Text] [Related]
23. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed. Dupont AG; Lefebvre RA; Vanderniepen P Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174 [TBL] [Abstract][Full Text] [Related]
25. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. Grenader A; Healy DP J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038 [TBL] [Abstract][Full Text] [Related]
26. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
27. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit. Zhu L; Zhao RR; Zhang WF Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574 [TBL] [Abstract][Full Text] [Related]
28. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. Kerns WD; Arena E; Morgan DG Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297 [TBL] [Abstract][Full Text] [Related]
29. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors. Schoffelmeer AN; Hogenboom F; Mulder AH J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877 [TBL] [Abstract][Full Text] [Related]
30. [Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes]. Zhang WF; Zhi JM; Guo W; Zhao RR; Jin GZ Zhongguo Zhong Yao Za Zhi; 2000 Aug; 25(8):497-500. PubMed ID: 12515216 [TBL] [Abstract][Full Text] [Related]
31. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. Clark KL; Hilditch A; Robertson MJ; Drew GM J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741 [TBL] [Abstract][Full Text] [Related]
35. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
36. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Eklöf AC Acta Physiol Scand; 1997 Aug; 160(4):311-4. PubMed ID: 9338511 [TBL] [Abstract][Full Text] [Related]
38. Effect of dopamine on the cyclic adenosine monophosphate generating system in the rabbit internal carotid and middle cerebral artery. Amenta D; Cavallotti C; Collier WL; De Rossi M; Ricci A; Amenta F Arch Int Pharmacodyn Ther; 1988; 291():96-103. PubMed ID: 2835025 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog. Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313 [TBL] [Abstract][Full Text] [Related]
40. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. McGonigle P; Boyson SJ; Reuter S; Molinoff PB Synapse; 1989; 3(1):74-82. PubMed ID: 2521960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]